$HGEN pioneering work on #GMCSF looks extremely valuable at the moment!

Looking forward to seeing the #Lenzilumab FDA Phase III clinical data

$GILD $REGN $JNJ $MRK $PFE $ABBV

https://t.co/OYfSh5jM4m